The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Hydatidiform Mole, Invasive

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Hydatidiform Mole, Invasive

 

High impact information on Hydatidiform Mole, Invasive

 

Chemical compound and disease context of Hydatidiform Mole, Invasive

  • Complete remission was achieved in 84.9% of cases of invasive mole and in 59.3% of cases of choriocarcinoma when 5-fluorouracil was used as the initial treatment [7].
  • However, the incidence of invasive mole in the bestatin group (2/25, 8%) was significantly lower than that of the non-bestatin group (7/24, 29.2%) [8].
  • The present report describes our experience with serious complications of a vincristine overdose in an 18-year-old female who had methotrexate-resistant invasive mole [9].
  • This study was performed to determine whether bestatin (Ubenimex) has clinical prophylactic effects on the onset of invasive mole and a direct inhibitory effect on the growth of hydatidiform molar cells [8].
 

Biological context of Hydatidiform Mole, Invasive

 

Gene context of Hydatidiform Mole, Invasive

 

Analytical, diagnostic and therapeutic context of Hydatidiform Mole, Invasive

References

  1. Structural differences found in the asparagine-linked sugar chains of human chorionic gonadotropins purified from the urine of patients with invasive mole and with choriocarcinoma. Endo, T., Nishimura, R., Kawano, T., Mochizuki, M., Kobata, A. Cancer Res. (1987) [Pubmed]
  2. Presence of alpha 2-macroglobulin in normal but not in malignant human syncytiotrophoblasts. Saksela, O., Wahlström, T., Lehtovirta, P., Seppälä, M., Vaheri, A. Cancer Res. (1981) [Pubmed]
  3. The expression and localization of neutral endopeptidase 24.11/CD10 in human gestational trophoblastic diseases. Ino, K., Suzuki, T., Uehara, C., Nagasaka, T., Okamoto, T., Kikkawa, F., Mizutani, S. Lab. Invest. (2000) [Pubmed]
  4. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Jun, S.Y., Ro, J.Y., Kim, K.R. Histopathology (2003) [Pubmed]
  5. Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line. Ho, C.K., Chi, C.W., Yu, K.J., Wang, S.Y. Int. J. Oncol. (1998) [Pubmed]
  6. Expression of epidermal growth factor receptor in gestational trophoblastic diseases. Balaram, P., John, M., Rajalekshmy, T.N., Nair, B., Schultz, G., Nair, K. J. Cancer Res. Clin. Oncol. (1997) [Pubmed]
  7. Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. Sung, H.C., Wu, P.C., Yang, H.Y. Am. J. Obstet. Gynecol. (1984) [Pubmed]
  8. Prophylactic effect of bestatin on the onset of invasive mole--clinical and fundamental studies. Asada, E., Mano, H., Yamada, A., Ino, K., Ishizuka, T., Goto, S., Tomoda, Y. Biotherapy (Dordrecht, Netherlands) (1992) [Pubmed]
  9. Toxicity of vincristine overdose in a patient with invasive mole. Takada, S., Chen, S.Z., Mori, H. Nippon Gan Chiryo Gakkai shi. (1989) [Pubmed]
  10. Immunohistochemical demonstration of relaxin in gynecologic tumors. Yki-Järvinen, H., Wahlström, T., Seppälä, M. Cancer (1983) [Pubmed]
  11. Mismatch repair gene promoter methylation and expression in hydatidiform moles. Chen, H., Ye, D., Xie, X., Lu, W., Zhu, C., Chen, X. Arch. Gynecol. Obstet. (2005) [Pubmed]
  12. Isoelectric heterogenity of human chorionic gonadotropin: Presence of choriocarcinoma specific components. Yazaki, K., Yazaki, C., Wakabayashi, K., Igarashi, M. Am. J. Obstet. Gynecol. (1980) [Pubmed]
  13. Enzymohistochemical study on the gestational choriocarcinoma: histochemistry of choriocarcinoma. Ito, H., Miura, S., Sekine, T., Ohsone, S., Hosokawa, T. Cancer Detect. Prev. (1981) [Pubmed]
  14. Choriocarcinoma and invasive mole. A review of 10 years' experience. Davey, D.A., Fray, R. S. Afr. Med. J. (1979) [Pubmed]
  15. Expression of epidermal growth factor in gestational trophoblastic disease (GTD). John, M., Rajalekshmy, T.N., Nair, M.B., Augustine, J., Schultz, G., Nair, M.K., Balaram, P. J. Exp. Clin. Cancer Res. (1997) [Pubmed]
  16. Serum prolactin levels and immunohistochemical localization of prolactin in trophoblastic disease. Ranta, T., Wahlström, T., Rutanen, E.M., Stenman, U.H., Seppälä, M. Acta pathologica et microbiologica Scandinavica. Section A, Pathology. (1981) [Pubmed]
 
WikiGenes - Universities